Protease-activated receptor PAR4 drives cardiac inflammatin in diabetes

被引：0
|
作者：
Fender, A. [1 ]
Stolte, S. [1 ]
Leineweber, K. [1 ]
Kamler, M. [2 ]
Dobrev, D. [1 ]
机构：
[1] Univ Duisburg Essen, Inst Pharmacol, Fac Med, Essen, Germany
[2] Univ Duisburg Essen, Dept Thorac & Cardiovasc Surg, Fac Med, Essen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2020年 / 393卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
46
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2
    Yong Zhang
    Guoyu Yu
    Yanjie Wang
    Yang Xiang
    Qian Gao
    Ping Jiang
    Jie Zhang
    Wenhui Lee
    Yun Zhang
    Cellular and Molecular Life Sciences, 2011, 68 : 3771 - 3780
  • [22] Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2
    Zhang, Yong
    Yu, Guoyu
    Wang, Yanjie
    Xiang, Yang
    Gao, Qian
    Jiang, Ping
    Zhang, Jie
    Lee, Wenhui
    Zhang, Yun
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (22) : 3771 - 3780
  • [23] PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
    Wilson, Simon J.
    Ismat, Fraz A.
    Wang, Zhaoqing
    Cerra, Michael
    Narayan, Hafid
    Raftis, Jennifer
    Gray, Timothy J.
    Connell, Shea
    Garonzik, Samira
    Ma, Xuewen
    Yang, Jing
    Newby, David E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (02) : 448 - 456
  • [24] Protease-activated receptors PAR2 and PAR3, but not PAR4 are expressed in neuroblastoma cells.
    Wermes, C
    Siebke, A
    Wilhelm, C
    Glüer, S
    Sykora, KW
    Welte, K
    Ganser, A
    von Depka, M
    BLOOD, 2001, 98 (11) : 78B - 78B
  • [25] Protease-Activated Receptor 4 (PAR4) Plays a Critical Role in Fetal Loss and Peripheral Thrombosis in a Mouse Model of Thrombophilia
    Siner, Joshua
    Freguia, Christian Furlan
    Maiden, Michael
    Liu, Jianhua
    Baila, Stefano
    Arruda, Valder
    BLOOD, 2011, 118 (21) : 173 - 173
  • [26] Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis
    Zhang, Xiaojun
    Jiang, Wen
    Richter, Jeremy M.
    Bates, J. Alex
    Reznik, Samuel K.
    Stachura, Sylwia
    Rampulla, Richard
    Doddalingappa, Dyamanna
    Ulaganathan, Sankar
    Hua, Ji
    Bostwick, Jeffrey S.
    Sum, Chi
    Posy, Shana
    Malmstrom, Sarah
    Dickey, Joyce
    Harden, David
    Lawrence, R. Michael
    Guarino, Victor R.
    Schumacher, William A.
    Wong, Pancras
    Yang, Jing
    Gordon, David A.
    Wexler, Ruth R.
    Priestley, Scott
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (05) : 3571 - 3589
  • [27] Protease-activated receptor-4 (PAR-4) is a novel mediator of vascular remodeling in diabetes
    Pavic, G.
    Rauch, B. H.
    Fischer, J. W.
    Schroer, K.
    Fender, A. C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S61 - S61
  • [28] Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon
    Mulè, F
    Pizzuti, R
    Capparelli, A
    Vergnolle, N
    GUT, 2004, 53 (02) : 229 - 234
  • [29] Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4)
    Mumaw, Michele M.
    de la Fuente, Maria
    Arachiche, Amal
    Wahl, James K., III
    Nieman, Marvin T.
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1165 - 1171
  • [30] Analysis of Protease Activated Receptor 4 (PAR4) By Histidine Hydrogen Deuterium Exchange
    Nieman, Marvin T.
    de la Fuente, Maria
    Miyagi, Masaru
    BLOOD, 2014, 124 (21)
12345